Shanghai, China, June 18, 2025 — Simcere Zaiming, an innovative oncology-focused subsidiary of Simcere Pharmaceutical Group (2096.HK) today announc...
- NextCure gains global rights to SIM0505 excluding greater China, where Simcere Zaiming will retain rights- ...
The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting held in Chicago from May 30 to June 03 2025 is one of the most important globa...
On May 10, 2025, Simcere Zaiming, an innovative oncology-focused subsidiary of Simcere Pharmaceutical Group (2096.HK), announced the publication of pi...
Staff
Current Brands of Products
Innovative Product Candidates
Covering Class III Hospitals
Covering Other Hospitals & Medical Institutions